Microglia Biomarkers
Microglia Biomarkers - Related Videos
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
04:45
Magnetic Isolation of Microglia from Mouse Pup Brains
0 Views •
2025
In this video, we describe a protocol for isolating CD11b cells, including microglia, from mouse pup brains using magnetic-activated cell sorting. The brain tissues are homogenized to obtain single-cell suspensions, which are incubated with anti-CD11b antibody-coated microbeads, followed by a magnetic column-based separation to purify the CD11b+ cell population.
11:28
Culturing Microglia from the Neonatal and Adult Central Nervous System
0 Views •
Cited by 35 •
2013
We outline methods for the efficient and quick isolation/culture of viable microglia from the neonatal cerebral cortex and adult spinal cord. The dissection and plating of cortical microglia can be accomplished within 90 minutes, with the subsequent microglial harvest taking place ~ 10 days following the initial dissection.
08:37
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
0 Views •
Cited by 16 •
2016
Microglia (immune cells of the brain), are used as a surrogate biosensor to determine how nanoparticles influence neurotoxicity. We describe a series of experiments designed to assay microglial response to nanoparticles and exposure of hypothalamic neurons to supernatant from activated microglia to determine neurotoxicity.
13:36
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
0 Views •
Cited by 37 •
2012
Microglia are resident macrophages that provide the first line of defense and immune surveillance of the central nervous system. MicroRNAs are regulatory molecules that play an important role in many physiological processes including activation and differentiation of macrophages. In this article, we describe the method for measurement of microRNAs in microglia.
FAQs
Because microglia change across tissue contexts and functional states, a single signal cannot represent the full range of biology. No one marker captures every microglial state. A stronger interpretation therefore considers what the selected target measures, then relates that signal to the tissue context rather than treating it as a complete microglial profile.
These targets provide marker-specific molecular information, but their presence should not be treated as interchangeable evidence of an identical microglial condition. IBA1, TMEM119, and P2RY12 may be examined as proteins or transcripts, depending on the assay. Comparing their signals with the chosen method and tissue context helps prevent overinterpreting any single readout.
Assay specificity and tissue context are central sources of variation. Immunohistochemistry, flow cytometry, transcriptomic profiling, and positron emission tomography do not present the same type of measurement: they can emphasize cellular, molecular, transcript, or imaging-level information. Consequently, similar-looking results may not answer the same biological question, and conclusions should be tied to the assay used.
They can support comparisons between homeostatic and disease-associated microglia, but they do not automatically establish a complete phenotype. Interpretation depends on the marker set, assay specificity, and tissue context. In neuroscience studies, the most defensible use is to treat biomarker patterns as evidence for comparison across conditions, rather than assigning a state from one isolated measurement.
Method selection should follow the information required. Immunohistochemistry can support tissue-based analysis, flow cytometry can support cellular measurements, transcriptomic profiling can examine transcripts, and positron emission tomography can measure targets such as TSPO in imaging studies. These options address different experimental readouts, so the platform should match whether the study emphasizes tissue, cells, transcripts, or imaging.
TSPO serves as an imaging target that can be measured with positron emission tomography. This makes it useful when a study requires an imaging-based readout rather than only tissue, cellular, or transcript-level analysis. Its signal still requires contextual interpretation, because biomarker meaning depends on assay specificity and the surrounding nervous-system tissue.
They help researchers compare microglial patterns across settings such as neurodegeneration, inflammation, injury, and brain development. The same broad goal can be approached through tissue staining, cellular analysis, transcriptomic profiling, or imaging, depending on the study design. These applications connect measurable microglial features with disease-related, developmental, or injury-associated questions.